Published in Blood Weekly, May 3rd, 1999
Recently, a new HTLV confirmatory assay (INNO-LIA HTLV I/II Ab [INNO-LIA]; Innogenetics, Ghent, Belgium) appeared to be useful in resolving indeterminate results by WB for well-defined HTLV sera (Zrein et al., Clin Diagn Lab Immunol, 1998;5:45-59).
Ester C. Sabino of Brazil's Fundacao Pro-Sangue and colleagues said this development prompted them to compare the new test with a commercial Western blot (WB) assay. As samples they used a large number of blood donations...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.